Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. - Wikidata - awgldk - TriplyDB

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

http://www.wikidata.org/entity/Q34487821

about

Immune signaling by RIG-I-like receptors Beyond empiricism: informing vaccine development through innate immunity research DNA vaccines: a simple DNA sensing matter?Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease Current prospects for RNA interference-based therapies Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination Molecular mechanisms for enhanced DNA vaccine immunogenicity.Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.An overview of the highly pathogenic H5N1 influenza virus.MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells.Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.The future of human DNA vaccines Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines RIG-I like receptors in antiviral immunity and therapeutic applications.Mechanisms of action of adjuvants Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.DNA-launched live-attenuated vaccines for biodefense applications.Immunologic mechanism of Patchouli alcohol anti-H1N1 influenza virus may through regulation of the RLH signal pathway in vitro.

P2860

Q24304438-4594EB87-4C51-4A2D-A4A7-DA3A20641B95 Q26824573-C30470C7-2773-4F03-BFA1-403CDB568B85 Q26859016-1F321291-26ED-4A59-979F-B7661026F123 Q26859021-D1DBF4B8-7B46-4E87-81D4-13CAACD82138 Q28081406-C7505411-0D94-4461-ADFB-359BE096BCC3 Q28235733-CD6F1648-9D6E-4E30-A235-993FB4A86B2E Q28236770-A904DBB9-1BD2-4A8A-BA41-4F293CC66EE7 Q30366743-C4665400-9C19-4449-8E77-669CCF19905D Q30367140-714A10C7-CD72-471A-BE89-D164159CC530 Q30418612-37F2F97B-3FAE-49EA-BB97-C41339667353 Q30426011-F36B5A8D-291C-49C9-A593-D5FAC822DD1B Q34506918-21DBD411-59B4-4DB9-A7FF-4CD6DFB1EA0E Q34671862-3E1CA3A9-1247-428E-A875-0B71BCC3A0D6 Q35826665-3402D621-4272-4ECD-9169-628AE8D45C05 Q36438236-0116EAF1-50C1-45B3-A435-FC185AF3167A Q36754331-091FAB9C-D071-40C7-AC41-A8B296CF46CC Q36977614-2032F511-0458-4118-B436-B64EA7693AC3 Q37478319-59B2BE08-DE4F-4B21-A0FD-ECB09303FB2B Q37945229-8E210B42-1285-430E-BF99-969F612184D1 Q38110539-3409E596-FCA7-42D8-82A6-FD5F39F4CFC0 Q38342834-EBAD2D92-3D0B-412D-95C5-A94343571148 Q38730774-1AD99035-271D-4DAF-AD38-F1E634603566 Q40110791-4F81CB5E-D44B-42D3-B664-F1E703DB153B Q44715130-50D36E10-B04D-48B7-B03B-6E29774EF80A

P2860

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

http://www.wikidata.org/entity/Q34487821

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@ast

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@en

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@nl

type

label

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@ast

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@en

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@nl

prefLabel

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@ast

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@en

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@nl

P1433

Q34487821-F961899B-7AAA-46BF-80A7-6BFC0CC85F5D

P1476

Q34487821-63BD9C8B-1E17-434D-BF82-8592C95B2F20

P2093

Q34487821-0A5E481E-C1AB-4366-88D2-B540958D5D10

Q34487821-68D55F5C-0AE7-4590-82FE-DA368B91F3BA

Q34487821-70F22310-BB90-4819-991F-DB62CC400CE6

Q34487821-A0E0CE2D-1721-455E-8EF1-46F2CEE6A484

Q34487821-C4DDE568-901C-40C0-821D-F3F7C56D1317

Q34487821-EA441DBE-F093-46BC-8D08-9A00486A68CF

Q34487821-FAB4C9B9-B334-4C74-899A-448B3D71FAF5

P2860

Q34487821-027EF5A6-1D62-48B2-9993-284C50BC4230

Q34487821-02E5074A-5013-42CE-B151-0216953412AE

Q34487821-060E3CB8-8432-4EBA-BA8B-EA5C40D6047B

Q34487821-0A8DD802-201C-464B-BB4D-33F5B9279BEA

Q34487821-0BCB1FEF-8676-4650-8DE9-080A9B345EAE

Q34487821-0E36A572-CFFA-486B-B5DF-5B72423C9DFC

Q34487821-176068E2-B182-4171-8577-AB6462F11DCF

Q34487821-1B4A37FA-6122-4D16-8B4B-D1339E670E58

Q34487821-1C295C99-CC29-4142-A6C9-3AAC69FCAA4E

Q34487821-21D24D25-A4A3-4463-8880-A8FB61DF300C

P304

Q34487821-E07B2E13-CD8B-482E-BB0C-85F9C68E98CD

P31

Q34487821-166146E5-76C7-495D-B206-52913864AEC7

P356

Q34487821-F6E6ABE9-0746-48A3-A3C9-EAB51A545C1E

P407

Q34487821-63E3B642-7C66-4354-8116-2BCB77C52EA6

P433

Q34487821-7D78DCB5-F836-4B2B-BDEC-280084E6C353

P478

Q34487821-D99767CB-54A8-42D6-8A3F-6257AB5E79DE

P50

Q34487821-A95F4DBF-5F14-4B80-B69F-2DBE84233B26

P577

Q34487821-19A8CCD1-A18E-4AAA-B515-EF4463998CD6

P5875

Q34487821-1124F0CB-E843-4238-B162-DFB4AECCE642

P698

Q34487821-1643524F-AA70-40A6-BCD9-B92F026B32F1

P932

Q34487821-31847229-90B6-411B-BDF5-B979B6B618E0

P356

P1433

Journal of Virology

P1476

Coexpressed RIG-I agonist enha ...... o influenza virus DNA vaccine.

@en

P2093

Clague P Hodgson

http://www.w3.org/2001/XMLSchema#string

Gregory G Simon

http://www.w3.org/2001/XMLSchema#string

J Thomas August

http://www.w3.org/2001/XMLSchema#string

James A Williams

http://www.w3.org/2001/XMLSchema#string

Jeremy M Luke

http://www.w3.org/2001/XMLSchema#string

John S Errett

http://www.w3.org/2001/XMLSchema#string

Jonas Söderholm

http://www.w3.org/2001/XMLSchema#string

P2860

The Gene Structure and Replication of Influenza Virus

IFI16 is an innate immune sensor for intracellular DNA

Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus

Activation of MDA5 requires higher-order RNA structures generated during virus infection

Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner

Mfold web server for nucleic acid folding and hybridization prediction

Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA I

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo

P304

1370-1383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01250-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49634976

http://www.w3.org/2001/XMLSchema#string

P698

21106745

http://www.w3.org/2001/XMLSchema#string

P932

3020507

http://www.w3.org/2001/XMLSchema#string